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ABSTRACT

CHARACTERIZING THE VIRULENCE FACTOR YAPE IN YERSINIA PESTIS
Tiva T. VanCleave
April 25, 2018

Yersinia pestis is the causative agent of bubonic plague and is primarily
transmitted by fleas. Upon infection, the bacteria rapidly travel to the regional
lymph nodes causing inflammation and cellulitis in these tissues (referred to as
buboes). Two outer membrane proteins, YapE and Pla, have been implicated to
have roles in dissemination to the lymph nodes. Their adhesive properties have
shown that they are able to interact with host macrophages thereby increasing
their ability to disseminate to regional lymph nodes. More recently, we have
shown that YapE is cleaved by another virulence factor important for lymph node
colonization, Pla, to become an active adhesin. To further understand the biology
of YapE, I used a transposon mutagenesis screen to identify possible regulators.
While the current approach did not identify novel regulators, I discuss potential
modifications to screening conditions that may allow for increased success in
future attempts. I also investigated the role that Pla may play in the activation or
degradation of other outer membrane proteins. 2-DIGE analysis identified 76 Y.
pestis proteins that may be processed by Pla and I confirmed Pla-dependent
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degradation on HmsF at 37°C. To further investigate the role outer membrane
proteins may play in intracellular survival, I infected macrophages with Y. pestis
strains lacking pla, yapE, ail or ompA. Before performing these intracellular
assays, I developed an optimized gentamicin protection assay to monitor
intracellular growth of Y. pestis. To this end, I determined that the concentration
of gentamicin used for Y. pestis should not exceed 8 µg/ml for 1 hour. Using this
assay, I verified that OmpA was required for Y. pestis intracellular survival in
macrophages. While Y. pestis lacking Pla or YapE had minor defects in
intracellular growth, an ail mutant showed no phenotype difference compared to
WT. Future studies with mutants lacking multiple adhesins will help to define the
potential contributions of these proteins to intracellular survival.
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CHAPTER ONE
YERSINIA PESTIS AND PLAGUE

1

Plague is an enzootic disease that has caused three pandemics worldwide [1].
These pandemics consisted of the Justinian plague (541 AD), The Black death
(1334 AD) and the current, Modern plague (1900 AD). The current pandemic,
Modern plague, came by way of infected rats that travelled on steamships from
Asia and spread among port cities around the world. This pandemic came to the
western shores of the United States, and can still be found in western states such
as

New

Mexico,

Arizona,

Colorado,

California,

Oregon,

and

Nevada

(https://www.cdc.gov/plague/maps/index.html). In the United States animals such
as rock squirrels, wood rats, ground squirrels, prairie dogs, chipmunks, mice,
voles,

and

rabbits

can

be

affected

by

plague

https://emedicine.medscape.com/article/235627-overview#a6).

(CDC

and

Plague

still

remains a significant concern for public health because of its ability to be
transmitted person to person through respiratory droplets and possible use in
bioterrorism and biological warfare [2, 3]. Currently, Y. pestis is listed as a Tier 1
Category A Select Agent due to its potential to be used as a weapon [3, 4].
From 1970-2016 there have been between 1-17 cases per year reported in the
United States (https://www.cdc.gov/plague/maps/index.html). Outside of the
United States, plague is much more prevalent, especially in Africa and Asia.
Currently, the Center for Disease Control (CDC) and the World Health
Organization report that as recent as August 1 – November 22, 2017 that in
Madagascar alone there were a total of 2348 confirmed cases of plague with a
fatality rate 8.6% (http://www.who.int/csr/don/27-november-2017-plaguemadagascar/en/).

2

Plague is caused by the Gram negative bacterial pathogen Yersinia pestis [5].
When transmitted by fleas, the bacteria initially colonizes the intradermal space
before migrating to the draining lymph node, where it causes inflammation and
cellulitis resulting in a bubo (bubonic plague) [6]. Left untreated, the bacteria can
escape from the lymph node and disseminate systemically through the blood to
various organs causing a fatal sepsis known as septicemic plague. Secondary
pneumonic plague occurs during the septicemic infection when the blood
circulating with the bacteria goes to the lungs. A primary pneumonic infection can
also occur by direct inhalation of infectious droplets or aerosols and develops into
acute pneumonia, intra-alveolar hemorrhage and edema, profound lobular
exudation, fibrin deposition, and bacillary aggregation [2, 7]. Due to acute and
systemic infections, the mortality rate of plague reaches 70-100% without
treatment depending on routes of infection [8].
Y. pestis virulence determinants
Y. pestis belongs to the family Enterobacteriaceae where Yersiniae contains 14
species, with three being pathogenic to humans [9-11]. Two are enteric pathogens,
Y. entercolitica and Y. pseudotuberculosis and the third, Y. pestis, is the agent of
plague. Y. pestis diverged from Y. pseudotuberculosis approximately 1,50020,000 years ago [12, 13]. During this divergence, Y. pestis acquired two additional
plasmids (pPCP1 and pMT1) that are necessary for transmission of the bacteria
from the flea vector to the mammalian host [5, 12, 13]. Furthermore, Y. pestis has
also acquired new virulence factors and lost genes that are required for enteric
infection but not for plague [5].
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1. Evasion of the immune response by the Ysc Type III Secretion System
(T3SS)
The T3SS is found on the pCD1 plasmid, which is present in all three
pathogenic species of Yersinia [5]. The assembly of the T3SS allows for
transport of effector proteins across the inner and outer bacterial membranes
of the bacterium in addition to across eukaryotic membranes [14]. These
effector proteins released through the T3SS are referred to as Yops (Yersinia
outer membrane proteins). The Yops allow for disruption of the cytoskeleton,
mediate cell adhesion, and facilitate the adherence of the T3SS for Yop
injections [14, 15]. In vivo, Y. pestis injects their effector Yops targeting
primarily neutrophils but also phagocytes such as macrophages and dendritic
cells although in vitro, they are able of injecting effector Yops into essentially
any cell [16]. The T3SS is expressed when inside a mammalian host (37°C)
and has no role in the colonization of the flea (26°C) [5].
There are seven Yops found in all three Yersinia spp.; YpkA/YopO, YopH,
YopE, YopJ/YopP, YopK, YopM, in addition to YopT that is only found in Y.
entercolitica. YpkA/YopO, YopE, YopT and YopH play a role in the disruption
of the actin cytoskeleton and target eukaryotic cell signaling components of the
RhoA family of small GTPases that facilitates the inhibition of phagocytosis
with the exception of YopH for the later [17, 18]. Additionally, YopH disrupts
both the innate and adaptive immunity pathways that are important for the
virulence of all three pathogenic species in mice [17, 19], in addition to
inhibiting autophagy and blocking phagocytosis in macrophages [17, 20, 21].
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YopP/J inhibit the ability to activate and release NF-Kβ, keeping the cell in an
anti-inflammatory state [22-26]. YopJ also has been shown to inhibit caspase-1
in activated macrophages [27]. YopM is essential for Yersinia virulence
because of its capacity to downregulate proinflammatory responses while
upregulating IL-10, an anti-inflammatory cytokine [28-31]. Comparable to YopJ,
YopM has been shown to block mature caspase-1 activity inhibiting the
recruitment of pro-caspase-1 to the inflammasome complex [32-34]. Loss of
the T3SS or the pCD1 plasmid results in complete attenuation of all three
pathogenic species in mice [18]. This further validates the importance that the
T3SS is vital for the virulence of the bacteria.
2. Modulation of LPS
One way that Y. pestis is able to avoid immediate clearance from the host once
infection has begun is to be able to sense the change in environment, and
change the conformation of its LPS when going from the flea to the mammalian
host. At 26°C (flea), the LPS is hexa-acylated which is recognized by TLR-4,
inducing proinflammatory cytokines such as IL-8, IL-1 and TNF. During a
temperature shift, that happens during infection into a mammalian host (37°C),
the LPS changes to the tetra-acylated form that does not stimulate TLR-4 and is
an antagonist for hexa-acylated LPS [35, 36]. To further validate the role the
change in LPS has on virulence, Montminy and co-workers altered the LPS of Y.
pestis to be a more powerful TLR-4 stimulant. The change to the stimulatory
form of LPS caused Y.pestis to be rendered completely avirulent after
subcutaneous infection [36].
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3. Iron uptake
Siderophore-based iron acquisition has been seen as a hallmark for virulence in
successful pathogenic bacteria [37]. This is true for the pathogenicity of
Yersiniae and its ability to acquire iron. All three pathogenic species of Yersinia
use the siderophore Yersiniabactin (Ybt) [37]. The iron accumulated from the
host allows for metabolic stability for the purpose of multiplying to cause systemic
infections [38]. Yersiniabactin synthesis in Y.pestis consists of irp1 and 2 and
ybtU,T,E and S, and are clustered on a mobile genetic element known as the
High Pathogenicity Island that makes it possible to be widely disseminated in
Enterobacteriacea [37]. This siderophore plays an important role in the
acquisition of iron and murine virulence [37, 39, 40]. Inactivation of Ybt has been
shown to significantly attenuate Yersinia [37, 39, 41-45].
4. Plasminogen activation by Pla
Pla is encoded on the plasmid pPCP1. pla was identified as one of the most
exceedingly expressed genes in Y. pestis isolated from bubos of infected rats
[46, 47]. Pla is a member of the omptin family of proteases that has evolved
specifically for bubonic and pneumonic forms of plague [48]. Pla is able to
convert plasminogen to plasmin allowing for the degradation of extracellular
matrices permitting Y. pestis to quickly invade the host and migrate to draining
lymph nodes [17, 49-51]. During subdermal or subcutaneous infection, Y. pestis
expressing Pla had wide-spread bacterial foci with minimal recruitment of
inflammatory cells [48, 52]. Conversely, when Pla was not expressed, it resulted
in an accumulation of bacteria at site of infection, causing an inability to
6

disseminate and thereby increasing the recruitment of immune cells [48]. Unlike
the bubonic (subcutaneous) model, Pla is not necessary for the dissemination
from the initial site of infection for primary pneumonic plague. Pla is pivotal for the
progression of primary pneumonic plague by assisting in the growth or survival
and proliferation of Y. pestis in the lungs [46, 53]. Pla is important for the fitness
of the bacteria for both bubonic and pneumonic plague although through differing
mechanisms. This shows the multifaceted nature of Pla, that while it is
dispensable for the spread of Y. pestis in pneumonic plague, its protease activity
is important during bubonic plague.
5. The Capsular antigen fraction 1 (Caf1) Capsule
The Caf1 capsule is made up of the Fraction 1 (F1) antigen, a fimbrial protein
that accrues on the bacterial surface to form a capsule unique to Y. pestis [54].
Caf1 capsule is strongly influenced by temperature, where essentially no
capsule is identified in the flea vector or at temperatures <35°C [54]. The caf1
gene is the most highly expressed genes during infection of the mammal,
indicating that it is a virulence factor [54]. Studies have shown that the capsule
works in tandem with the T3SS to make Y. pestis resistant to uptake by
macrophages and PMNs [55-58]. Although the caf1 gene is highly expressed,
there has been conflicting data on its requirement for virulence [56, 59]. Some
studies with bubonic plague in mice and guinea pigs, and pneumonic plague in
primates, have shown that when the F1 capsule is not present, there is no effect
on virulence [56, 60, 61]. Conversely, Gonzalez and co-workers were able to
show that in C57BL/6J mice a Δcaf1ΔpsaA strain had a significant attenuation in
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dissemination or colonization into deeper tissues from the lymph node compared
to the WT Y. pestis [59]. However, the same Δcaf1ΔpsaA strain was not
attenuated in BALB/cJ mice [62]. The previous findings by Weening and coworkers showed that differences in virulence with caf1 was predicated on the
mouse background [62]. Although there appears to be evidence that the capsule
plays a minor role in virulence, depending upon host; it has been shown that
minute amounts of the F1 subunits and the outer membrane Caf1A protein have
an affinity to the IL-1 receptor on macrophages and to IL-1β expression by
epithelial cells [63-65]. This may play a role in early infection by conferring
adhesion or anti-immunity potential [54].
6. Y. pestis Adhesins
The ability to target cells for T3SS has been directly linked to bacterial adhesins
[66]. In the enteropathogenic Yersiniae, two important adhesins, YadA and
Invasin, facilitate bacterial attachment and Yop injection [14, 15]. Although
these two adhesins are important for the pathogenicity of Y. entercolitica and Y.
pseudotuberculosis, yadA and inv are pseudogenes and not expressed in Y.
pestis [17]. Therefore, other adhesins, have taken on the roles of YadA and Inv.
Ail
Ail functions as a multi-factorial adhesin in Yersiniae [17]. During its divergence
from the two enteric pathogens, it gained additional roles in the virulence of Y.
pestis that include; 1) facilitating the injection of Yops into host cells [14, 67], 2)
inhibition of the inflammatory response [68], 3) inhibition of the bactericidal
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properties of complement [68-70]and 4) prevention of neutrophil recruitment to
the lymph nodes [69, 70]. Ail has been shown to be the primary adhesin in the
attachment of the T3SS to host cells in Y. pestis where its deletion exhibits
significant reduction in binding to epithelial and monocytic cells [17, 70].
Interestingly, the transcription of Ail can also be altered when other outer
membrane components are mutated [70]. In addition when comparative
proteome strategies were used to identify new virulence targets found that Ail
clustered together with virulence associated proteins on the plasmid pCD1.
Pla
In addition to being a protease, Pla also has adhesive properties [71]. It has been
linked to invasion of host immune cells and dissemination by its interaction with
CD205 on macrophages [72]. A pla mutant is attenuated in a mammalian host
due to both its inability to disseminate from the site of infection and through its
uptake by macrophages. In addition to attachment to phagocytes, Pla is also
necessary for the positioning of the T3SS for the delivery of Yops [71].
YadB/C
YadB and YadC have the ability to form oligomers that lead to aggregation and
mediate invasion to epithelial cells, although they are not necessary for host cell
adherence [72, 73]. Studies have shown that when both proteins are mutated,
there is a substantial decrease in the ability for the bacteria to invade HeLa cells
and type I pneumocytes, but does not affect overall adherence to cells [73].

9

Autotransporters
Autotransporters are found in Gram-negative bacteria and are comprised of a Nterminal signal sequence, passenger domain, and C-terminal β-domain. Within the
Yersiniae species there are nine Yersinia autotransporter proteins (Yaps) that
produce functional proteins [74]. Autotransporters can contribute to pathogenesis
through adherence to eukaryotic cells, proteolysis, complement resistance and
cytotoxicity [75]. One particular autotransporter that has been conserved in all
three pathogenic species is YapE.
YapE
YapE has been maintained in all the pathogenic species of Yersiniae [76]. The
conservation of yapE in Yersinia suggests that YapE may be a virulence factor.
YapE is capable of facilitating contact between bacteria and eukaryotic cells
through its adhesive properties [76]. YapE also promotes adherence to
eukaryotic cells. This was demonstrated by Lawrenz and co-workers with the
evaluation of the adherence of bacteria to RAW264.7 macrophage cells. They
found that the expression of native YapE in Y. pestis had a significant increase of
adherent bacteria (3.5 fold increase, P<0.0001).
YapE also allows for of aggregation in Y. pestis and Y. pseudotuberculosis but
not in its distant relative, Y. entercolitica when expressed in E.coli [76]. A study by
Lawrenz and co-workers showed that the processing of YapE by the omptin, Pla,
is specific to Y.pestis but not its enteric predecessors [77]. The post-translational
modification of YapE appears to have been acquired after Y. pestis diverged
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from Y.pseudotuberculosis and Y. entercolitica [77]. As well as allowing for
bacterial aggregation, this processing was also shown to be necessary for the
adhesion to eukaryotic cells [76]. Their data showed that processing by Pla is
necessary for YapE to play a role in bacterial aggregation and eukaryotic cell
adhesion.
7. Role of intracellular survival
Y. pestis is considered a facultative intracellular pathogen due to its ability to
replicate in macrophages and neutrophils [5, 78, 79]. During a subcutaneous
infection (bubonic), there is a robust innate immune response with an immediate
arrival of both neutrophils and macrophages. However, initial neutrophil killing of
the bacteria is greater because the bacteria has not had an opportunity to employ
many of its anti-phagocytic properties during the transitional phase from the flea
to a mammalian host. Following infection with Y. pestis, neutrophils are rapidly
employed to the site and phagocytose the bacteria. Macrophages also engulf the
bacteria, although to a lesser degree, and appear to move away from the site of
infection [80]. It has been shown that although neutrophils have a high success
rate of eliminating Y. pestis, a small number of Y. pestis is still able to replicate
inside the hostile environment [78]. Due to the attenuated lifespan of neutrophils,
dying neutrophils are cleaned up by resident macrophages. Once the bacteria is
taken up by the macrophage, it is housed in a Yersinia containing vacuole (YCV)
where it is able to subvert the phagolysosomal degradation pathway [81]. The
intracellular lifecycle of Y.pestis has been shown to be important for virulence.
This has been exhibited by lower bacterial burden when animals were depleted
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for dendritic/macrophage populations during plague infection and survival defect,
in macrophages, by a phoPQ mutant [30, 80, 82-85].
Central hypothesis and Aims
YapE mediates interactions with macrophages and is required for disseminated
disease. Therefore, my central hypothesis is that YapE-dependent interactions
with macrophages contribute to overall virulence of Y. pestis. The following aims
were designed to further understand the biology associated with YapE.
Aim 1: Identify genetic regulators of yapE in Y. pestis.
Aim 2: Determine if other outer membrane proteins are processed by Pla.
Aim 3: Determine if YapE and/or Pla contribute to intracellular infection.
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CHAPTER TWO
IDENTIFICATION OF REGULATORS OF YAPE

13

Introduction
Bacteria regulate the expression of genes in response to the environment in
order to survive in specific niches. Virulence determinants are tightly and
coordinately regulated during infection. Virulence-related regulators can sense
host signals (e.g., changes in temperature) and then differentially regulate large
sets of genes required for adaptation to the host niche [86]. In the case of
pathogens, virulence genes are regulated in a coordinated fashion to allow the
bacterium to infect its host. Y. pestis is maintained in an enzootic cycle between
mammalian and insect hosts [87] and several studies have shown tight regulation
of virulence factors in Y. pestis dependent on host [74, 88, 89].
yapE transcription levels are very low during in vitro growth [74]. To evaluate in
vivo transcription, Lenz and co-workers used both a bubonic and pneumonic
plague model, and compared transcription levels of yapE, yapG and yapC grown
at 26° in broth cultures [74]. They observed a significant increase in yapE
expression in vivo compared to in vitro. Following subcutaneous infection, yapE
transcript increased 15-fold increase in expression of yapE in cervical lymph nodes
by 72 h and an approximate 5-fold in the lungs during pneumonic plague [74]. This
increase of expression in vivo, for both the pneumonic and bubonic models,
suggest that YapE may be important for mammalian infection [6]. In addition to
observing the differing levels of transcription in both models. Differences in levels
of yapE expression between the lymph nodes and lungs may suggest that yapE
has a more substantial role in bubonic infection than pneumonic infection. This
was confirmed when using a bubonic mouse model (subcutaneous) and

14

challenging with a yapE mutant and parental WT (CO92) strain. Colonization of
proximal lymph nodes had a noticeable delay in colonization compared to WT by
36 hours post infection. When the same challenge was performed on a pneumonic
plague model (intranasal), the mutated yapE strain did not significantly alter the
ability for the lungs to be colonized [76].
To further understand what stimuli is responsible for the change of expression
between the in vivo and in vitro testing, the bacteria were subjected to varying
stimuli such as temperature, iron, calcium, and pH in vitro [74]. None of these
environmental ques changed the expression of yapE in vitro [74]. To this end, it
was surmised that there must be other signals in vivo, that allows the bacteria to
streamline gene expression.
These findings support the hypothesis that yapE transcription is regulated in Y.
pestis. Here I attempted to elucidate the regulatory mechanisms for yapE
expression. Defining these mechanisms will help us to better understand how Y.
pestis regulates gene expression in response to host colonization.
Materials and methods
Construction of the yapE reporter in Y. pestis CO92 pCD1-∆lacZ∆yapE
background
The bacterial strains and plasmids utilized in this study are listed in Table X. Y.
pestis was grown in Brain Heart Infusion (BHI) broth at 26°C. Antibiotics were used
at the following concentration: chloramphenicol, 12.5 µg/ml (Yersinia).
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The promoter regions upstream from the yapE gene were amplified by PCR with
primers DNA278 (5’ – GG GGT ACC C TGG CTA TCA TTG TTT TAC GAA AGC
– 3’) and DNA368 (5’ – G GGA TCC CTT ATG GCT TGC TGA TAA TAG CAG
AGT – 3’). The resulting product was gel purified and digested with KpnI and
BamHI. The resulting fragment was ligated onto pFU99 and transformed into
YPA109 to generate YPA111.
Transposon Mutagenesis
YPA111 was grown in BHI broth at 26°C in chloramphenicol 12.5 µg/ml and E.
coli (S17) containing the transposon pAJD428 (LOU117) was grown in LuriaBertani (LB) broth at 37°C in Kanamycin 50 µg/ml. In a separate tube, a 3:1
(LOU117:YPA111) was added to sterile 10 mM MgSO4. The mixture was then
placed into the 3 cc syringe attached to a Swiznet filter containing a membrane
filter (0.45 um HV) allowing the solution to be pushed through the membrane
filter. Using flame sterilized tweezers, the membrane was removed from the filter
and placed on a BHI agar plate that has no antibiotic and allowed the bacteria to
grow overnight at 26°C. The following day the membrane was removed from the
agar plate and placed into a 1.5 ml tube with 1X sterile PBS and vortexed for 45
seconds. The bacteria was then plated the rehydrated bacteria (straight) onto
BHI agar plates containing; Kanamycin 100 µg/ml, Chloramphenicol 12.5 µg/ml,
Polymyxin 25 µg/ml, X-gal80 µg/ml and IPTG 1mM and allowed to grow for 2
days at 26°C. Colonies that were blue were then grown for further evaluation.
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DNA Isolation
Blue colonies that developed on the mating plate were isolated and grown in BHI
broth overnight. The following day 1.5 mls of the bacteria were pelleted by
centrifugation and re-suspended in a buffer of 50mM Tris and 50 mM EDTA.
10%SDS and Pronase were added to the re-suspended bacteria and allowed to
incubate for 1 hour at 42°C until the solution was clear. Phenol was added and
the mixture was shaken for one hour. To the mixture, chloroform was added and
centrifuged for 15 minutes at 7,000 x g. The top phase was transferred into a
clean 1.5 ml Eppendorf tube and 3M of sodium acetate (NaOAc) and 95%
ethanol was added and inverted allowing the DNA to precipitate out of solution
and the DNA was rinsed with cold ethanol. To the rinsed DNA, TE and RNase
was added and allowed to incubate at 37OC for 1 hr allowing the DNA to unwind
into solution. After incubation, sodium acetate and cold isopropyl alcohol is
added to the solution containing the DNA and centrifuged for 10’ @ 13,000 RPM.
The remaining pellet was washed 2 x with 70% EtOH and the DNA was allowed
to dry for 30 minutes at room temperature. The dried pellet was then re-suspend
DNA 200 in µl H2O for further evaluation.

Arbitrary PCR
To identify the insertion site of the transposon from the isolated DNA above, we
performed two rounds of PCR with the first round amplifying the junction between
the TnMod-RKm’-laclq-tacp (pAJD428) and the Y. pestis chromosome using 5’GGC CAC GCG TCG ACT AGT ACN NNN NNN NNN ACG CC-3' (DNA457) and
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5'-GAC AAT TAA TCA TCG GCT CG-3' (DNA458). The PCR was ran on an 0.8%
agarose gel and then the PCR product was then purified using the Promega PCR
clean up kit and eluted in ddH2O. The purified PCR product was then amplified for
the transposon using primers 5'-GGC CAC GCG TCG ACT AGT AC-3' (DNA459)
and 5'-TCG GCT CGT ATA ATG TGT GG-3' (DNA460). Again, the PCR was ran
on a 0.8% agarose gel for verification. The resulting PCR was then then purified
using the Promega PCR clean up kit and eluted in ddH2O and sent for sequencing
using M13 reverse primer

5'-AGC GGA TAAC AAT TTC ACA CAG GA-3'

(DNA461). When the results were returned, the inverted repeats were identified
(TGAACACATATTCTCAGTC) and the sequence upstream of the inverted repeats
were placed in NCBI BLAST to identify the region of insertion in the Y.pestis
chromosome.

Construction of the inducible phage construct
The genetic regions YPO2277-2281 were amplified using 5'- CGC ACT GAC CCA
ATT CGA GCA GAA CAG AAG CGC C -3' (DNA567) and 5'- TTC GAT ATC AAG
CTT ATC GAT ACC GTC GAC TCA CCA ATC AGG CCT -3'(DNA581) and the
inducible plasmid, pMWO-034 was amplified using 5'- GGC GCT TCT GTT CTG
CTC GAA TTG GGT CAG TGC G -3' (DNA570) and 5'- AGG CCT GAT TGG TGA
GTC GAC GGT ATC GAT AAG CTT GAT ATC GAA -3' (DNA580). The PCRed
vector, pMWO-034, was digested with DpnI and incubated at 37 for 1 hour. Gibson
cloning was performed by adding the amplified phage region (YPO2277-2281) to
the vector and incubated at 50° for 1 hour and placed on ice. The assembled
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reaction was dialyzed for 20 minutes and electroporated into DH5α cells and
recovered in room temperature LB broth. The electroporated DH5α cells were
incubated on the roller drum for 1 hour at 37°C. The reaction was then plated onto
LB/Kan50 plates and placed in the 37°C overnight.
Confirmation of phage insertion into pMWO-034 plasmid
Clones from the assembled Gibson cloning of the phage region (YPO2277-2281)
were grown in LB broth overnight at 37°C and the plasmids were extracted using
the Wizard® Plus SV Minipreps DNA Purification System. The plasmids were then
subjected to restriction digest with BamHI for 3 hours and then ran on an 0.8%
agarose gel to confirm insertion.
Miller Assay for induction of phage in high salinity and high osmolarity
Bacterial strain YPA111 was grown in BHI at 26°C overnight and diluted 1:12.5
into 5 mls of M9 media and allowed to grow for 1 hour at 26°C. After the first
hour, 1 mM IPTG was added to the media containing the phage containing strain
YR076 and placed on the roller drum to incubate for 2 hours at 26°C (T=3h). To
the respective sample, to test for stress induced by salinity, 5M NaCl was added
to the media for a final concentration of 0.5M NaCl for high salinity; the bacteria
experiencing high osmolarity sorbitol was added to the culture for a final
concentration of 0.5M sorbitol for 20 minutes. OD600 readings were taken after 20
minutes of growth for all samples NaCl, sorbitol and both controls. Assay tubes
were set up to include the Z buffer containing 60 mM disodium phosphate, 40
mM monosodium phosphate, 10 mM potassium chloride and 10 mM magnesium
sulfate and β-mercaptoethanol. To the buffer, chloroform and 0.1% SDS was
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added. Cells were added to working buffer and lysed immediately by vortexing
for 10 seconds. The samples were allowed to incubate at room temperature for 5
minutes.
The β-galactisidase reaction began by adding ONPG as well as the timer to
begin the reaction and quickly vortexed. After sufficient color change, the
reaction was completed by adding Na2CO3 and the stop time was recorded. The
sample was quickly vortexed and allowed to sit for 5-10 minutes allowing the
particulates settle. Once the reactions were completed, the top layer was
transferred into a cuvette, and the absorbance was measure at OD420 and OD550.
1. Determine Miller Units using the following formula:
Miller Units = 1000 x [(OD420 - 1.75 x OD550)] / (T x V x OD600)


OD420 and OD550 are read from the reaction mixture.



OD600 reflects cell density when harvested.



T = time of the reaction in minutes.



V = volume of culture used in the assay in mLs.

Results:
Transposon mutagenesis screen
To identify gene(s) that are involved in the regulation of yapE, we designed a
reporter system where we fused the promoter region of yapE to a lacZ gene that
gives a colormetric readout when the transposon inserts itself into gene(s) that
may influence yapE regulation (Fig. 2-1). Using this reporter strain, a transposon
library was generated, using the Tn5 pAJD428 transposon. The pAJD428
transposon is different from the traditional Tn5 transposon that it also contains an
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outward facing lac promoter. This allows for the observation of both positive and
negative regulators. The limitation of the Tn5 is that the only regulator that can be
screened is a negative regulator. The pAJD428 transposon, because of the
outward facing lac promoter, is able to also screen positive regulators. This can be
observed when plated in the presence of IPTG that will drive the lac promoter
allowing continued transcription of the gene in which the transposon inserted. Over
54,000 colonies were screened using the pAJD428 with 100 containing the blue
phenotype indicating increased expression of yapE.
To determine if the transposon inserted itself into a positive or negative regulator
of yapE, I grew each blue colony in the presence or absence of 1 M IPTG. Colonies
that turned white in the absence of IPTG, were designated IPTG dependent,
suggesting transposon insertion upstream of a positive regulator. Those that
remained blue in the absence of IPTG were designated IPTG independent,
suggesting insertions into negative regulators (Table 2-2). Of the 100 original
colonies 36 were IPTG dependent.
Identification of transposon insertions
Genomic DNA was isolated from each clone and arbitrary PCR was performed to
identify the genomic area where the transposon inserted. 22 were found in sugar
transport and metabolizing genes, 56 were inserted into the reporter plasmid, 1
into an E.coli DNA polymerase II, and 1 into a phage-related membrane protein. I
was not able to identify insertion sites for 20. Due to the nature of the screen, the
sugar transport and metabolizing genes were not further investigated because they
fell into an operon containing lacI and a putative galactosidase gene (Table 2-1).
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Since the readout is from cleavage of X-gal by β-galactasidase it was determined
that these may be false positive.
Identification of Phage insertion
From the 100 colonies that were isolated, one insertion, that was IPTG
independent, was in a phage related membrane protein (Table 2-1). During the
screen there were instances where there was a secondary insertion one in the
reporter plasmid and one in the secondary region. To ensure there was no
secondary insertion causing the change in yapE expression, plasmid isolated from
the clone containing the phage insertion (YR076), the vector plasmid, and a
sample that had a known insertion into the plasmid (YR100) were cut by restriction
digest to linearize the plasmid and compare the sizes (Figure 2-3). An increase in
size would denote an insertion of the transposon in the reporter plasmid. To this
end, it was verified that there were no additional insertions in the reporter plasmid.

Determining if insertion in the Phage-like protein influences yapE expression.
To determine if the transcription of the phage shock protein is regulating yapE, an
inducible phage was designed consisting of the phage-like and secretion proteins
sequence and the two hypothetical proteins flanking that region. The transposon
inserted itself between YPO2278 and YPO2279 and I wanted to include the genes
upstream and downstream of the insertion site (Fig.2-5).
The genomic region used for the inducible plasmid codes for the filamentous
phage, YpfΦ. We first wanted to determine if induction of this phage would alter
the growth of the bacteria. To determine if there was a growth defect, OD600
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readings were taken every 2 hours for 8 hours of YR076 (induced with IPTG and
uninduced), vector containing strain (YPA111) and WT (YPA035). Induction of
YR076 was performed after 1 hour of initial growth. Over the first 6 hours there
was no difference between ODs of each of the samples. By hour 8, there was a
slight decrease in OD in both the induced and uninduced YR076 although it was
shown to be statistically insignificant (Fig. 2-4). Since there was no change in
growth when the phage protein was expressed by the YR076 clone, I decided to
perform a β-galactosidase assays placing the YapE reporter strain (YPA111) in
stress conditions to activate the native phage.
Phages are activated under stressful conditions and produce a protein termed
phage shock protein (psp). The phage shock protein response is well
characterized in Y. pestis predecessor, Y. entercolitica. These proteins are
required for regulation and stress tolerance [90]. Lenz and co-workers have
previously shown that when Y. pestis is placed under environmental stressors,
there was an influence in the expression of several Yaps (Table 2-2). Although,
there was no change in vitro when placed under these stressors, there was an
increase in vivo of yapE at 37°C. Three stressors that were not evaluated in the
Lenz screen were, low Mg2+ concentration, osmolality and salinity. To determine if
one of the aforementioned stressors may have some influence on the phage
transcription, I decided to perform a Miller assay (β-galactosidase assay) using the
yapE reporter strain (YPA111). Compared to the control, YR076, there was no
change in expression of the yapE promoter region for any of the three stressors
(Fig 2-7 and 2-8).
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Because I was unable to activate the native phage, the inducible phage protein
plasmid that was constructed was tested next. By Western blot analysis, the
inducible plasmid containing strain (YPA131) was compared to an inducible strain
of CO92 containing a yapE overexpression plasmid (YPA024). Because
endogenous YapE is so low in vitro, the use of an overexpressing strain for yapE
allows for verification of YapE in addition to having the ability to quantify the overall
amount of protein produced. The both samples (YPA131 and YPA024) were
induced with anhydrous tetracycline (aTc) or no anhydrous tetracycline were
added to the samples (negative control). Samples were acquired every 2 hours for
6 hours and the Western blot membrane was probed with 1:1000 α-yapE.
Compared to the overexpression YapE strain, there was no visible detection of
YapE at any of the time points from the samples containing the inducible phage
(Fig. 2-6). As stated earlier, previous studies by Lenz and Lawrenz, YapE
expression is low in vitro and an overexpression plasmid was required to observe
YapE by Western blot. Another possibility for a negative blot is that the amount of
YapE expressed may be below the limit of detection by Western blot analysis.
Discussion
Initially, I previously screened over 15,000 clones using a Tn5 transposon and
acquired 75 clones containing the blue phenotype. The initial use of the Tn5
limited the scope of identifying regulators because the only regulators that could
be identified were negative regulators. To increase the scope of the screen, I
changed to the pAJD428 transposon. Much like the Tn5, pAJD428 consists of
inverted repeats and a kanamycin cassette but it also contained an outward
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facing inducible lac promoter. If the transposon inserted itself into a negative
regulator, thereby inactivating the repressor, would allow for increased activity of
yapE promoter. This allowed for the observation of both negative and positive
regulators by way of dependence or independence of IPTG. To this end, I was
able to perform a >10-fold coverage screen of the Y. pestis genome, screening
54,931 colonies for changes in yapE expression using the pAJD428 transposon.
YapE is a highly conserved autotransporter and has been shown to be a
virulence factor due to its increased upregulation in vivo at 37°C, ability to
adheres to RAW macrophages by 3.5-fold, and displays a delay in dissemination
and colonization of the lymph nodes [76]. Because bacteria coordinate
expression of virulence factors, we sought to investigate the mechanism of how
yapE was being regulated. To this end, we used a transposon mutagenesis
screen to try to identify gene(s) responsible for yapE regulation. We performed a
10-fold coverage of the Y. pestis genome and were able to isolate 100 clones
that had the blue phenotype representing an insertion into a possible regulator of
yapE either a positive regulator or a negative regulator. What we found is ~85%
of the transposons inserted themselves into our reporter or sugar transport and
metabolizing genes. The remaining clones were either not verifiable due to not
being able to locate the inverted repeats or we were unable to obtain verifiable
data from sequencing. We did find one insertion a filamentous phage, YpfΦ that
has been shown to confer some selective properties to Y. pestis during the
infection process [91].
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Filamentous phage infections produce the protein, phage shock protein, when
the bacteria are in stressful conditions [92]. When infection occurs from the flea
vector to the human host, Y. pestis goes through copious changes due to its
ability to infect two different host the flea at 26°C and the mammalian host at
37°C. Once inside the mammalian host, the bacteria are subjected to
temperature shift, pH change, in addition to the influx of neutrophils and
macrophages that phagocytize the bacteria placing them under highly stressful
conditions. Lenz showed that using environmental cues in vitro had no effect on
yapE transcription levels but in vivo (37°C) they showed that yapE transcript
increased 15-fold by 72 hours [74]. This indicates that there may be other stress
inducers or environmental cues in vivo that may influence transcription levels of
yapE.
Although we were not able to detect any yapE transcription by way of our
reporter, this may be due to the length of time the bacteria was placed in high
stress environment (up to 12 hours). Lenz showed the increase of transcript of
yapE, in vivo, was between 48 and 72 hours [74]. The time points analyzed here
may not have been long enough to allow for the regulator to be induced.
In addition to the genes of the phage, we also cannot rule out the possibility that
this was another case of false positive due to a lacI transcriptional regulatory
protein downstream of the phage related membrane proteins (Fig. 2-2) and the
insertion in the phage operon may have induced expression of this gene and
production of a cryptic β-galactosidase.
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Another caveat to the transposon screen is that yapE expression is already low
in vitro. When designing the reporter, there is a chance there was YapE
expression but the limit of detection by Western blot was not able to detect the
protein. Alternately, YapE expression in a potential yapE regulatory mutant may
have been toxic. To try to avoid this, I used a ∆yapE strain.
When identifying gene regulators, there is the possibility that regulation may be
multifactorial. The screens limitation is that it did not taking into consideration the
impact of temperature, pH, oxygen or other environmental cues may have on
yapE regulation. In the future, screens for yapE regulators should be performed
in the presence of factors that mimic the host would be advantageous. This
would include growing the cultures containing the transposon insertion at both
26° and 37° and in the presence of 5% CO2. Because yapE is upregulated in the
host, another possibility is to use to perform the screen in macrophages. After
infection, macrophages could be lysed and bacterial RNA purified and perform
qRT-PCR performed on yapE to determine if insertion influences transcriptional
change in yapE.
An alternative possibility is that the regulator may be a sRNA. Small RNAs, are
small (50-250 nucleotide) non-coding RNA molecules produced by bacteria [93].
These small molecules have been shown to have regulatory function that
include, gene expression that affects protein synthesis at the post-transcriptional
level [94]. We may have missed sRNAs in our transposon mutagenesis screen
due to their small nature.

27

Although we were unable to identify a regulator of yapE, we believe that this
should be followed up using alternative methods and to possibly investigate
sRNAs as possible regulators that would not be identified by this method.

28

Table 2-1 Transposon mutagenesis screen.
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Table 2-2 Growth and stress conditions of Yersinia autotransporter
proteins

Bacteria
Type of stress
Y.pestis Temperature (not extreme
temp)
Calcium

Iron
pH

Results
 ≥2-fold @37°-yapF, yapJ, yapK,
yapL and yapM
 15-fold increase in yapE (in lymph
nodes)
 Only 2 genes responded to CA
levels, yapK and yapM.
 yapM was induced @26° and
 yapK was repressed in the
presence of calcium at 37°
 other yap genes showed no change
in expression levels
yapM was the only gene found to be
responsive to low-iron conditions where it
was repressed at both 26° and 37°
 Under acidic conditions (pH 6.0) no
yap genes were induced
 @ pH of 6.0 yapG was repressed
>2-fold
 @pH of 8.0 yapG was repressed
2.5 fold @ 26°
 yapH was induced 3.5-fold at pH
8.0 and 26°

Table adapted from Lenz, JD et al., 2011 [74]
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Figure 2-1. Schematic of Transposon Mutagenesis Screen
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Figure 2-2. Transposon insertion site into Phage related membrane protein
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Figure 2-3. There is no secondary insertion in clone YR076. Plasmid DNA
from the reporter (pFU99), YR076, and a clone containing an inserted
transposon in the reporter (YR100) was linearized using BamHI and ran on a
0.8% agarose gel. The reporter and clone YR076 both migrated to approximately
6.8 kb showing that there is no other insertion found in YR076.
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Growth curve of YR076
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Figure 2-4. Growth curve of YR076 clone. Growth curve showing OD600
readings over 8 hours of growth when clone YR076 is induced with IPTG and not
induced compared with the vector strain YPA111 (pFU99::yapE) and the wildtype strain YPA035 (CO92 pCD-). 2-way ANOVA showed no significance at the 8
hour time point.
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Rep Origin 1
pSC101 ori

Multi-cloning site

pMWO-034::YPO2277-2281
7811 bp

YPO2281

-35 Signal 1
-10 Signal 1

YPO2280a
YPO2280

YPO2277 (partial)
YPO2278
YPO2279

Figure 2-5. Inducible plasmid for the phage-like membrane protein
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Figure 2-6. Western blot analysis of inducible phage plasmid. YPA001 w/
YapEYpestis tetO expresion plasmid (YPA024) and the phage-inducible plasmid
(YPA131) induced and uninduced were grown at 26°. Whole cell lysate was
acquired at T=2h, 4h, and 6h. The red arrow shows YapE.
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Figure 2-7. The native phage, YpfΦ, was not induced by salinity or
osmolarity. The reporter strain (YPA111) was grown at 26° in the presence of
5M NaCl2 or 5M sorbitol for 20 minutes and yapE::lac expression was measured
by Miller Assay. The clone containing the transposon insertion into the phage,
YR076, was induced with IPTG and used as a positive control. YPA111, grown in
media with no added stressors for a negative control.
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Figure 2-8. Low Magnesium is not an environmental cue for YapE.
The reporter strain (YPA111) was grown at 26° in the presence of 10 µM MgCl2
or 1mM MgCl2 and a Miller Assay was performed to measure yapE promoter
activity at 5, 8, and 12 h. The clone containing the transposon insertion into the
phage, YR076, was induced and used as a positive control. The reporter strain,
YPA111, was just grown in media with no added stressors for the negative
control. Due to the extreme elevation of Miller units for the YR076 (I), this data
was not shown. Data shows three biological replicates for each concentration.
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CHAPTER THREE
SURFACE PROTEINS CLEAVED BY THE PLA PROTEASE
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Introduction:
Pla a 9.5 kd protein located on the pPCP plasmid (also known as pPst) of Yersinia
pestis, and has been shown to be responsible for the invasive property of plague
in the mammalian host [95]. Pla, a member of the omptin family of enterobacterial
surface protein, is a multifunctional protein that can activate the mammalian
plasma proenzyme plasminogen into plasmin [49]. In addition to being able to
activate plasminogen into plasmin, Pla also cleaves the complement C3
component [52], modifies bacterium-produced Yops (Yersinia outer proteins) [96,
97], has the ability to activate adhesins (YapE) and proteolytically inactivates α2antiplasmin [98, 99].
YapE facilitates contact between bacteria and eukaryotic cells through its adhesive
properties [76]. Lawrenz and co-workers showed that YapE adhesive properties is
predicated upon its cleavage by Pla. This was the first indication that Pla may
cleave other bacterial outer membrane proteins.
Therefore I sought to determine if other Y. pestis outer membrane proteins are
cleaved by Pla.
Material and Methods:
Membrane Fractionation
Y. pestis CO92 pCD1(-) (with and without pla) were grown, overnight, at 26°C in
Brain Heart Infusion (BHI) broth (Difco). The overnight culture was then subdiluted into BBL BHI, where CaCl2 was added to the media at a final concentration
of 2.5 mM and allowed to agitate on a floor shaker for approximately 3 hours at
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26°C and 37°C. The bacteria was grown to an optical density of ~2 OD600/ml and
approximately 300 ODs were harvested. The harvested bacteria was then
centrifuged for 10 minutes at 4,000 xg at 4°C. The supernatant was removed and
the bacteria were washed 3X with 25 mls of 10 mM HEPES, pH 7.5, 1x protease
inhibitor. Bacteria was re-suspended into 10 mM HEPES, pH 7.5, 1x protease
inhibitor and transfer to 50 ml conical for sonication. The bacteria was then
sonicated in 3 cycles at 30% amplitude for one minute on ice. The sonicated
fractions were then centrifuged for 2 minutes at 1,000 x g at 4°C. The supernatant
was transferred into ultracentrifuge tubes for ultracentrifugation at 100,000 xg for
30 minutes at 4°C. Supernatant was removed and the pellet was re-suspended in
0.3% Sarkosyl, 10 mM HEPES, pH 7.5, 1x Protease inhibitor and incubated at
room temperature for 30 minutes. The outer membranes were pelleted by ultracentrifugation at 100,000 x g for 30 min. at 20°C. The inner membrane proteins in
the supernatant were removed and the pellet was dissolved in molecular grade
water.
Chloroform-methanol extraction
To the outer membrane fraction methanol was added and vortexed thoroughly.
Chloroform and water were added, vortexed, then centrifuged for 1 min at 14,000
x g. The top aqueous layer was removed and placed in a separate Eppendorf
tube where methanol was added and vortexed. The fraction was then centrifuged
for 5 min at 20,000 x g. The methanol was removed leaving a pellet that contains
the outer membrane proteins. The pellet was then lyophilized by speed vac. The
pellet was then sent to ABI for 2-D gel analysis.
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2-D gel analysis
2-D DIGE gel analysis was performed on the lyophilized protein sample (~500
ug) from the outer membrane prep stated previously. The sample was sent to
AppliedBiomics where they performed 2-D DIGE analysis on the 4 samples
consisting of WT CO92 Y. pestis at 26° and 37° and CO92 Δpla at 26° and 37°.
2-D DIGE analysis consist of cross-gel analysis containing an internal control,
comprised of an equal mix of all 4 samples, loaded on both of the analytical gels.
The first analytical gel compared the protein profile of WT CO92 Y. pestis at 26°
and CO92 Δpla at 26°and the second gel consisting of WT CO92 Y. pestis at 37°
and CO92 Δpla at 37°. By having an internal standard being loaded on both gels
allowed for the comparison of spots across the two gels.
The protein expression profiles acquired by AppliedBiomics consisted of: i) the
raw data of both gels (WT26°/Δpla26° and WT37°/ Δpla37°),ii) a protein ID
number, iii) master number, iv) appearance, and v) ratio treatment/control.

Gel image report. The overlay of both gel images were compared where the red
and green spots represent up- and down- regulated proteins, respectively.
DeCyder analysis software was employed to analyze the quantitative changes in
protein between the samples. The software was able to calculate the log value of
the standardized abundance of the selected spot for each sample. The samples
were then grouped into control and treatment and the average was taken of each
group. It also allowed for the evaluation of the fold change (increase of
decrease) of each spot was indicated.
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Results:
2DIGE and MS/MS determination of outer membrane proteins processed by Pla
To ascertain outer membrane proteins whose expression changes when Pla is
absent or present, I employed the methods of 2-DIGE and mass spectrometry.
WT and ∆pla strains were grown at 26° and 37°, outmembrane proteins isolated
and labeled with a fluorescent dye. Proteins were separated by 2-DIGE and
compared (WT/∆pla at 26° and 37°) Differences between the proteins were
analyzed. Applied Biosystems (ABI) was able to identify 76 distinct protein IDs
that were assigned by their DeCyder software. Of the 76 proteins identified, we
chose 10 to further investigate by way of MS/MS. Our criteria for choosing the
protein was that there was a ≥ 2-fold increase or decrease when grown at both
26° and 37° between WT and ∆pla. To this end, we chose the proteins identified
in Fig.1. Of these spots, serine endoprotease (spot 16), SodC (spot 61),
Glutamine sythetase (spot 63) and Inosine-5’-monophosphate (spot 72) are not
outer membrane proteins and removed from further consideration. The remaining
six peptides were two forms of Pla (spot 37 & 48), HmsF (spot 5), OmpA (spot
40), OmpX/Ail (spot 51) and Omp85/YaeT (spot 9).
Western blot analysis for Ail and HmsF:
To confirm the results from 2DIGE, I chose two proteins, Ail and HmsF. Total
outer membrane proteins were isolated from WT or a Δpla strain of Y. pestis
grown at 26°C to 37°C and separated by SDS-PAGE. Proteins were probed with
α-Ail or α-HmsF antibodies. When probing with α-Ail, there was no change in Ail
expression from 26°C and 37°C or between WT and ∆pla (Fig. 3-2). When
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evaluating the difference in protein expression of HmsF, at 26°C there was no
difference in protein amounts between the HmsF over expressing strain, the pla
mutant and WT (Fig. 3-3). Conversely, a substantial reduction of HmsF was
observed at 37°C in WT Y. pestis versus the ∆pla mutant, indicating that Pla
degrades HmsF.
Discussion:
Using a pla mutant we were not surprised that the first and highest on the list was
Pla itself. Pla is able to autoprocess itself into three forms, alpha, beta, and
gamma. These forms of Pla consist of α-Pla (43%), β-Pla (30%) and γ-Pla (16%)
[99]. α-Pla corresponds to the full-size mature Pla where β and γ-Pla are the
subsequent processing of α-Pla [100] [97, 101]. The autoprocessing of Pla was
further shown by Kukkonen and co-workers using mutations in Pla that
compromised its proteolytic activity, resulting in loss of the beta form of Pla.
During our screen we found it interesting that HmsF was found to be significantly
increased when Pla was removed from Y. pestis. HmsF [102] is one of two outer
membrane proteins that are in the hmsHFRS operon. The hmsF operon is
located in the pgm locus and is required for hemin storage. This operon has been
showed to play an important role in its ability to block the proventricular valve in
the flea allowing for the transmission of the bacteria from the flea to mammalian
hosts [102]. Although Perry and co-workers showed that the expression of the
hmsHFRS operon was not predicated by temperature we found that there was a
difference in protein when Pla was absent at 37° [102]. The reason for the
possible reduction of HmsF at 37°C is that Pla activity is optimal at 37°C where
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Pla activity is reduced at 26°C. Since the genes expressed in hmsHFRS operon
play a role in biofilm formation, this phenotype would not be advantageous to the
bacteria when moving into a mammalian host. This leads us to conclude that the
reason that posttranslational modification to HmsF allows for the inhibition of the
biofilm that is needed for transmission from the flea but would hinder its mobility
inside of a mammalian host.
OmpA has been a highly characterized outer membrane protein that has been
shown to facilitate adhesion to and/or invasion of eukaryotic cells, in addition to
conferring serum resistance [103]. OmpA has also been shown to mediate
adhesion and/or invasion of eukaryotic cells and serum resistance [104].
The attachment invasion locus (Ail) is an outer membrane protein that is
expressed in all three pathogenic species of Yersinia and is thermally regulated
and is expressed fully at 37°C [105, 106]. Although Ail is expressed in all three
species to aid in the adherence of host cells, its role in the virulence of Y. pestis
is more pronounced. This is due to Y. pestis no longer having functional YadA
and invasin due to a frame shift mutation or transposon insertion [107]. One of
Ail’s primary role is to facilitate the attachment to host cells for the delivery of Yop
effector proteins from the T3SS. In addition to attachment, Ail is also important in
the evading of host immune responses allowing for rapid progression of infection
[108].
It is also important to note that the regulation of these genes are varied with
respect to pla expression (Table 3-3). To this end, we have a better
understanding of the dual nature of Pla and its interplay among various outer
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membrane proteins and possible explanations on its attenuation when mutated
outside of a reduction in dissemination, but also the attenuation it has
intracellularly. Although we only evaluated the top 10 proteins, other proteins
identified in the 2-D gel analysis may give us further insight into novel proteins
that are either activated or degraded by Pla, and whether Pla process contributes
to virulence.
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Figure 3-1. 2-DIGE outer membrane protein spot identification. Outer
membranes from WT (green) and ∆pla (red) grown at 37°. The first analytical gel

compared the protein profile of WT CO92 Y. pestis at 26° and CO92 Δpla at 26°and the
second gel consisting of WT CO92 Y. pestis at 37° and CO92 Δpla at 37°. The overlay
of both gel images were compared where the red and green spots represent up- and
down- regulated proteins, respectively. The white circles indicate proteins where the

ratios were ≥2-fold difference between temperature and strain. The pink circles
indicated the proteins chosen for MS/MS analysis.
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Figure 3-2. Western blot analysis of Ail at 26°C and 37°C in the presence or
absence of pla . WT and ∆pla strains were grown to mid-exponential phase at
26°C and 37°C and collected by centrifugation. Outer membrane proteins were
extracted, and 1.5 OD600 of each sample was analyzed by Western blot and
probed with 1:40,000 α-Ail.
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HmsF Δpla37° WT37° ∆HmsF
ΔHmsF

HmsF (~76 kD)

Figure 3-3. Western blot analysis of HmsF in the presence and absence of
pla at 37°C. WT and ∆pla strains were grown to mid-exponential phase at 26°C
and 37°C and collected by centrifugation. Outer membrane proteins were
extracted, and 1.5 OD600 of each sample was analyzed by Western blot and
probed α-HmsF (1:40,000). HmsF+(over expression strain: positive control),
∆HmsF (negative control).
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Table 3-1. 2-DIGE Analysis
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Table 3-2. MS/MS Analysis of peptides chosen from the 2-DIGE Analysis.
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Table 3-3. Yersinia pestis outer membrane regulators.
Gene

Regulator

pla

cyclic AMP
receptor protein
(Crp)

hmsF

fur

ompA

micA

ail

Upregulated at 26°

Upregulated at 37°

√
√
√
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√
√

CHAPTER FOUR
IMPACT OF GENTAMICIN CONCENTRATION AND EXPOSURE TIME ON
INTRACELLULAR YERSINIA PESTIS1

_______________________________
VanCleave TT, Pulsifer AR, Connor MG, Lawrenz MB. Impact of Gentamicin
Concentration and Exposure time on Intracellular Yersinia pestis. Front Cell Infect
Microbiol. 2017 Dec 11;7:505. doi:10.3389/fcimb.2017.00505. PubMed PMID:
29312891.
1
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Introduction
Many bacterial pathogens have evolved mechanisms to infect and survive
within host cells. Therefore, in order to study and understand the pathogenesis of
intracellular pathogens, cell culture-based in vitro assays have been developed.
For obligate intracellular pathogens, like Chlamydia species, which cannot grow
outside of a host cell, these assays are relatively straight forward. Bacteria are
added directly to cells, allowed to adhere and invade for a certain period of time,
and the remaining extracellular bacteria are removed by washing the cells [109,
110]. However, for facultative intracellular bacteria that can also replicate in
tissue culture medium, additional steps are needed to inhibit the growth of
extracellular bacteria not removed by washing. The most common approach to
limit extracellular growth is to include an antibiotic to the medium after bacteria
have had time to invade cells. Importantly, the antibiotic chosen should have a
limited ability to cross the plasma membrane of the cell. Thus, intracellular
bacteria are protected from the antibiotic while extracellular bacteria are inhibited
by the antibiotic (commonly referred to as an antibiotic protection assay) [111,
112]. Application of the antibiotic protection assay has allowed the study of
intracellular virulence mechanisms across multiple facultative intracellular
bacteria [113].
While the antibiotic protection assay is commonly used to study intracellular
pathogens, strong evidence indicates that antibiotics originally thought to be
completely excluded by the host cell can slowly enter and accumulate within
cells. For example, aminoglycosides such as streptomycin and gentamicin are
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often employed in the antibiotic protection assay because they are not lipid
soluble and original studies indicating poor cell permeability [114-116]. However,
subsequent studies have demonstrated that despite poor membrane
permeability, aminoglycosides can still accumulate within cells to levels that
inhibit bacterial growth, especially for organisms that remain in vacuolar
compartments. Such phenomenon has been reported for antibiotic protection
assays involving Listeria monocytogenes, Salmonella enterica, Staphylococcus
aureus, and E. coli [117-120]. The increased sensitivity of organisms within
phagosomal compartments to aminoglycosides, as opposed to those that escape
into the cytoplasm, has been attributed to the believed primary route of antibiotic
uptake – pinocytosis of the extracellular milieu [117]. Pinocytosed vesicles
containing the antibiotic in turn readily fuse with phagosomes/endosomes,
delivering the aminoglycoside to the bacterial containing compartment. However,
it should be noted that aminoglycosides have also been shown to accumulate in
the cytosol depending on the cell type used and length of incubation time with the
antibiotic, and thus, addition of aminoglycosides may also artificially influence
intracellular growth of cytoplasmic pathogens [117, 121]. Therefore, these data
should be taken into consideration when designing antibiotic protection assays to
study intracellular growth.
Yersinia pestis, the causative agent of plague, is a facultative intracellular
pathogen that is able to invade and replicate in host cells [58, 78, 81, 82, 122124]. Of particular interest has been Y. pestis intracellular survival in
macrophages [81, 125]. However, Y. pestis has also been shown to survive in
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epithelial cells [107] and more recently, within neutrophils [122, 126-128]. As Y.
pestis does not express many extracellular virulence factors in the flea vector,
it is believed that intracellular survival is important during the early stages of
infection after transmission from the flea, and provides a protective niche for
the bacterium to initiate expression of the factors needed to exist extracellularly
[81, 82, 88, 124, 129]. Once Y. pestis invades a cell, it is able to generate a
replicative niche within a phagosomal compartment (called the Yersinia
containing vacuole or YCV) by subverting the normal maturation of the
phagosome [83, 130-132]. The YCV appears to be maintained throughout the
intracellular infection until the host cell eventually lyses, releasing the bacteria
into the extracellular environment [131].
As Y. pestis is able to grow in most cell culture media, in order to study
intracellular interactions with host cells in vitro, the antibiotic protection assay is
needed to inhibit extracellular growth. In most cases gentamicin is the primary
antibiotic employed for Y. pestis intracellular studies because the bacterium is
sensitive to the antibiotic (MIC ~2 µg/ml) [133]. Surprisingly, in light of the
potential influence gentamicin has on the intracellular growth of other bacteria,
a large variety of gentamicin concentrations (ranging from 0.016-256 µg/ml)
and incubation times (from 15 min to 2 h) have been reported in the Y. pestis
literature [78, 122, 134-138]. Not surprisingly, variation in Y. pestis intracellular
survival has also been observed. Importantly, characterization of potential Y.
pestis pathogenesis factors involved in intracellular infection, or attempts to
repeat published data, could be influenced simply by the concentration of
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gentamicin used in the antibiotic protection assay. Therefore, we felt it was
imperative to understand the potential influence of gentamicin concentrations
on Y. pestis intracellular growth in order to eliminate any potential for
unintended influence of the gentamicin protection assay on the interpretation of
intracellular studies with Y. pestis.

MATERIAL AND METHODS
Cell culture and bacterial strains
Primary peritoneal macrophages were harvested from 8-12 week old C57/Bl6
mice (University of Louisville IACUC Protocols 16651 and 16723) injected with 3
mls of sterile Brewer’s thioglycolate medium. Four days after injection, mice were
humanely euthanized and peritoneal macrophages were recovered in 20 mls of
Hank’s Buffered Salt Solution (HBSS). Cells were isolated by centrifugation and
resuspended in 10 mls of DMEM (DMEM, 100 mM glucose, sodium pyruvate;
Hyclone) + 10% FBS (Biowest) as previously described [139]. Cells were
quantified, transferred to microtiter plates or dishes, and allowed to adhere for 3
h. Non-adherent cells were then removed from adherent macrophages by
washing with HBSS three times. RAW264.7 macrophages were originally
obtained from ATCC and cultured in DMEM + 10% FBS. RAW264.7 cells were
propagated for only up to 15 passages for these studies. Y. pestis strains used in
these studies are listed in Table 1. Bacteria were propagated in Difco Brain Heart
Infusion (BHI) (BD, Co.). We have previously shown that the bioluminescence
generated by the LuxPtolC bioreporter directly correlates with bacterial numbers
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and can be used to kinetically monitor Y. pestis intracellular survival in
gentamicin protection assays [130, 140].
Live Cell Microscopy
5 x 105 peritoneal macrophages in FluoroBrite DMEM (ThermoFisher), 4 mM
glutamine + 10% FBS were added to a 35 mm glass bottom FluoroDish (World
Precision Instruments). Macrophages were allowed to adhere to the dish for 3 h
prior to infection. Y. pestis was grown overnight in BHI broth at 26oC and then
diluted 1:25 in fresh BHI broth and grown for an additional three hours until the
culture reached an absorbance at 600 nm of ~1.0. The bacteria were diluted into
FluoroBrite DMEM, 4 mM glutamine + 10% FBS and added to macrophages at a
multiplicity of infection (MOI) of 3 bacteria per macrophage. To facilitate cellbacteria interactions, FluoroDishes were centrifuged at 200 x g for 5 minutes and
returned to the CO2 incubator. Fifteen min later, the medium was removed, the
cells were washed three times with sterile 1X PBS to remove extracellular
bacteria, and fresh FluoroBrite DMEM, 4 mM glutamine + 10% FBS was added.
Live imaging was performed using a Nikon A1 confocal microscope (Nikon
Instruments, Inc.) with a live cell chamber equilibrated to 5% CO2 and 37°C prior
to imaging. Either a 488 nm or 561 nm laser with filter sets 525±50 nm or 595±50
nm were used to visualize EGFP or mCherry, respectively. Images were taken
using a 40x Plan Fluro Oil objective every 20 min beginning 1 h post-infection
and continuing for 24 h. The Nikon Perfect Focus System and field tiling were
used to collect six fields (287 x 287 µM per field) at each time point. Bacterial
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numbers were estimated by calculating the area of the fluorescent signal for each
field using FIJI [141].
Monitoring bacteria using a bioluminescence
1.5 x 105 macrophages were aliquoted into the wells of a white 96 well microtiter
plate (Greiner Bio One) and allowed to adhere for 3 or 15 h (peritoneal or
RAW264.7 cells, respectively). Y. pestis was grown overnight in BHI broth at
26oC and then diluted 1:25 in fresh BHI broth and grown for an additional three
hours until the culture reached an absorbance at 600 nm of ~1.0. The bacteria
were diluted into 37oC DMEM +10% FBS and added to macrophages at a MOI of
10 bacteria per macrophage. To facilitate cell-bacteria interactions, microtiter
plates were centrifuged at 200 x g for 5 minutes and returned to the CO 2
incubator for an additional 15 minutes, at which point gentamicin was added
directly to the wells without washing to achieve the final desired concentrations.
Concentrations of gentamicin used were not cytotoxic to macrophages. Bacterial
numbers as a function of bioluminescence produced by the LuxPtolC bioreporter
[130, 140] was monitored kinetically to limit manipulation of the macrophages
using a Synergy HT plate reader (0.5 sec read, sensitivity of 135) (BioTek) or
IVIS Spectrum camera system (15 min read, 500 nm emission filter) (Caliper).
Determination of gentamicin minimal inhibitory concentration
Y. pestis was grown overnight in BHI broth at 26oC and then diluted 1:25 in fresh
BHI broth and grown for an additional 3 h until the culture reached an
absorbance at 600 nm of ~1.0. The bacteria were diluted into 37 oC DMEM + 10%
FBS and aliquoted at 1.5 x 106 CFU per well in a 96 well plate. Gentamicin was
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diluted in 37oC DMEM + 10% FBS and added to the bacteria to achieve the final
desired concentration (0 – 128 µg/ml). One h after treatment, bacterial numbers
were determined by conventional enumeration using serial dilution and plating on
BHI agar [140].
Enumerating intracellular bacteria by conventional enumeration
For short incubations with the antibiotic, bacterial numbers were directly
enumerated by serial dilution to allow for separate calculations of extracellular
and intracellular bacterial numbers after gentamicin treatment. Macrophages
were infected with Y. pestis as described above and treated with gentamicin for 1
h. After treatment with gentamicin, the culture medium was collected into a
separate tube, the cells were washed three times with sterile 1X PBS, which was
also collected and combined with the collected medium, the combined medium +
1x PBS washes was serial diluted and plated on BHI agar plates to enumerate
the extracellular bacteria. For the intracellular bacteria, washed macrophages
were lysed with 0.1% Triton X100 and serial dilutions were plated on BHI agar
plates for enumeration [140].
Statistical Analysis
All studies were repeated three times to ensure reproducibility. When needed,
mean values from individual treatment groups were compared to the 0 µg/ml
gentamicin group using the ANOVA with the Dunnett’s post test or across all
samples with the Tukey post test. A p-value less than 0.5 was consider to be
statistically significant.
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RESULTS
Macrophage - Y. pestis interactions in the absence of gentamicin. To
establish the fate of Y. pestis during infection of macrophages in the absence of
gentamicin treatment, primary peritoneal macrophages were infected with a Y.
pestis strain expressing the mCherry fluorescent protein (YPA165). 20 min postinfection, the macrophages were washed to remove extracellular bacteria and
imaged every 20 min by laser confocal microscopy for 24 h (data not shown).
Changes in bacterial number, as a function of the total area of mCherry signal,
were calculated at each time point (Fig. 4-1). Over the first ~12 h, most bacteria
appeared to be intracellular and we observed a steady increase in the area of
mCherry over time, indicating intracellular survival and growth (Fig. 4-1A).
However, a small number of infected macrophages began to lyse ~12 h postinfection and release Y. pestis into the culture medium, though cell death was not
synchronous and most infected cells were still intact through the first 18 h (Fig 41C). We continued to observe increases in the area of mCherry through 24 h of
observation (Fig. 4-1B), and while bacteria appeared to continue to grow
intracellularly, extracellular bacteria released from dead macrophages were also
replicating in the medium and represented a large portion of the mCherry signal
at later time points (Fig. 4-1B and C). By 24 h post-infection, almost all of the
infected macrophages had lysed and the majority of the mCherry signal was from
extracellular bacteria (Fig. 4-1C).
To determine if the Y. pestis Ysc type 3 secretion system (T3SS) influenced the
intracellular fate of the bacterium, macrophages were infected with a Y. pestis
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strain lacking the pCD1 virulence plasmid encoding the Ysc T3SS and
expressing EGFP (YPA081) and imaged by laser confocal microscopy as
described above. As observed for the T3SS positive strain, total area of EGFP
increased over the entire course of the experiment (Fig. 4-1A and B). However,
unlike the Y. pestis pCD1(+) strain, we did not observe macrophage lysis,
bacterial release, or extracellular proliferation over the 24 h time frame of the
experiment, indicating that the increased area of EGFP was a function of only
intracellular growth. Together these data: 1) confirm data from previous in vitro
assays that Y. pestis survives intracellularly in primary macrophages [123, 132];
2) confirm that Y. pestis lacking the T3SS can survive in macrophages [78, 123,
132]; 3) demonstrate that macrophages infected with Y. pestis with a functional
T3SS lyse more rapidly than macrophages infected with Y. pestis lacking the
T3SS; 4) macrophage cell death releases intracellular bacteria into the
environment; and 5) bacteria released from macrophages are viable and can
replicate in the cell culture medium. While intracellular vs. extracellular bacteria
can be differentiated during live imaging, in vitro assays that do not use
microscopy are not able to differentiate between the two, thus requiring the use
of an antibiotic protection assay. However, as a wide variety of concentrations of
gentamicin have been reported in the Yersinia literature [78, 122, 134-138], we
next wanted to determine if extended incubation with gentamicin could influence
intracellular proliferation of Y. pestis.
Extended incubation with gentamicin impacts intracellular survival of Y.
pestis. The simplest antibiotic protection assay would be to add gentamicin to
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the infected cells and maintain that concentration in the medium throughout the
entire course of the study. However, extended incubations have been shown to
influence the intracellular proliferation of other bacteria [111, 117, 118]. To
determine if extended incubations with gentamicin impacted survival of
intracellular Y. pestis, peritoneal macrophages were infected with a Y. pestis
strain containing the LuxPtolC bioreporter (YPA050), which we have previously
shown can be used to accurately monitor intracellular Y. pestis as a function of
bioluminescence [130, 140]. Twenty min post-infection, serial dilutions of
gentamicin were added to each well to achieve final concentrations of 128 to 1
µg/ml and beginning 2 h after infection, and bacterial numbers, as a function of
bioluminescence, were determined every 3 h for 20 h using a plate reader. We
observed that at the lowest concentrations tested, 1 and 2 µg/ml, that bacterial
bioluminescence increased over time, although at 2 µg/ml, bioluminescence was
approximately 2-3 fold lower than at 1 µg/ml (Figure 4-2A and 4-2B). At
concentrations greater than 2 µg/ml, bioluminescence no longer increased,
indicating that bacteria were no longer able to proliferate. At 4 µg/ml, we
observed an initial decrease in bioluminescence between 2 and 5 h, at which
time bioluminescence remained constant over the remainder of the assay.
Gentamicin concentrations greater than 4 µg/ml resulted in a steady decrease in
bacterial bioluminescence over the entire course of the assay (Fig. 4-2D-H).
Compared to our live imaging experiments without gentamicin, these data
demonstrate that extended incubation with even low concentrations of
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gentamicin can have a dramatic influence on Y. pestis intracellular survival, and
can lead to intracellular killing of the bacterium.

Sensitivity to gentamicin is cell type dependent. As pinocytosis is suggested
to be the main mechanisms for gentamicin uptake by macrophages, sensitivity of
intracellular bacteria to gentamicin could vary depending on cell type used.
RAW264.7 cells are an immortal cell line originally derived from mouse
macrophages and are commonly used as a macrophage model [142]. To
determine if the sensitivity of intracellular Y. pestis to gentamicin could vary
depending on cell type, RAW264.7 cells were infected with Y. pestis YPA050. 20
min later, serial dilutions of gentamicin were added to each well to achieve final
concentrations of 128 to 1 µg/ml and cells were incubated for 20 h. Bacterial
numbers were monitored as a function of bioluminescence, normalized to T=2 h,
and compared to similarly treated primary peritoneal macrophages (Fig. 4-3).
Similar to peritoneal cells, bacterial bioluminescence increased in RAW264.7
macrophages when treated with 1 µg/ml, indicating intracellular proliferation.
However, unlike bacteria in peritoneal macrophages, Y. pestis bioluminescence
continued to increase in RAW264.7 cells until gentamicin concentrations reached
16 µg/ml. After 16 µg/ml, bioluminescence began to decrease overtime,
indicating bacterial killing, and approached levels similar to that seen for
peritoneal macrophages at 128 µg/ml. These data highlight that gentamicin
inhibition of intracellular Y. pestis can vary between cell types.
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Short incubation with high concentrations of gentamicin inhibits
intracellular growth. Since extended incubations with gentamicin dramatically
inhibited the proliferation of intracellular Y. pestis, we next sought to identify the
minimal concentration of gentamicin needed to inhibit Y. pestis growth in tissue
culture medium in a 1 h period. Towards this end, Y. pestis YPA050 was diluted
in DMEM, 10% FBS with increasing concentrations of gentamicin. One h after
addition of gentamicin, bacteria were serially diluted and plated on BHI agar to
determine remaining viable bacteria (Fig. 4-4A). All doses of gentamicin tested
resulted in a significant decrease in the number of recovered bacteria compared
to untreated (p≤ 0.0001) and the degree of inhibition was dependent on the
concentration of the antibiotic. While bacteria were reduced ~1,000-fold within
one h with 4 µg/ml gentamicin, no detectable viable bacteria were recovered after
incubation with ≥8 µg/ml. Similar inhibition was observed for the Medivalis biovar
KIM D19 (Fig. 4-7).
Next we sought to determine whether the presence of macrophages impacted
the minimal concentration of gentamicin required to inhibit Y. pestis growth in cell
culture medium. Peritoneal macrophages were infected with Y. pestis YPA050
for 20 min and serial dilutions of gentamicin were added to each well to achieve
final concentrations of 128 to 1 µg/ml. One h after addition, the gentamicin
containing medium was removed and combined with washes and viable
extracellular bacteria were determined by serial dilution and conventional
enumeration (Fig. 4-4B). Extracellular bacterial numbers were significantly lower
in all the samples that received greater than 1 µg/ml of gentamicin as compared
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to absence of gentamicin (p≤ 0.0001). However, no significant differences were
observed in bacterial numbers between concentrations of 4 to 32 µg/ml.
Furthermore, while we observed no significant difference in bacterial numbers
between the 64 and 128 µg/ml concentrations, we observed ~2.5-fold lower
numbers of extracellular bacteria at 64 and 128 µg/ml samples (average 180
CFU) compared to the 4 to 32 µg/ml samples (average 458 CFU) that was
statistically significant (p≤ 0.05).
Finally, we enumerated the number of intracellular bacteria in macrophages
after 1 h treatment with gentamicin at both 1 and 24 h post-treatment to
determine if gentamicin concentration during short incubations could impact
intracellular survival of Y. pestis (Fig. 4-5). At 1 h post-treatment, statistically
significant differences in the number of intracellular bacteria recovered were not
observed until gentamicin concentrations were greater than 8 µg/ml (Fig. 4-5A).
In concentrations greater than 8 µg/ml, a dose dependent decrease in viable
intracellular was observed. However, even at the highest doses, intracellular
numbers only varied by ~1.3-fold as compared to macrophages receiving lower
doses of antibiotic. To determine if long term intracellular survival of Y. pestis
was affected by short exposures to gentamicin, a separate group of infected cells
were washed 1 h after gentamicin treatment to remove residual gentamicin and
fresh medium without gentamicin was added. 23 h later, the medium was
removed, the cells were washed, lysed, and intracellular bacterial numbers were
enumerated (Fig. 4-5B). We observed bacterial proliferation in all samples
containing less than 64 µg/ml gentamicin, and there were no significant
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differences in intracellular numbers in samples containing 0 to 32 µg/ml
gentamicin. However, bacteria did not proliferate in macrophages treated with 64
µg/ml of the antibiotic, and at the highest dose of 128 µg/ml, intracellular bacterial
numbers decreased over time. Together these data indicate that at least 4 µg/ml
of gentamicin is required to achieve optimal killing of extracellular Y. pestis in 1 h
during macrophage infection assays. However, as gentamicin concentrations
increase, even short incubations with the antibiotic can impact proliferation of
intracellular Y. pestis, especially at higher doses of the antibiotic.

Optimized gentamicin protection assay for Y. pestis
Together these data suggest that an optimized gentamicin assay for Y. pestis
should include two doses of gentamicin. The first should be an initial dose to
efficiently kill the majority of the extracellular bacteria in a short incubation period
(e.g., one hour) without inhibiting intracellular survival. The data from short term
incubations with gentamicin (Fig. 4-5) suggest that this concentration should not
exceed 8 µg/ml. After the one hour incubation, the medium should be removed
as continued incubation in 8 µg/ml results in inhibition of intracellular bacteria
(Fig. 4-2). The medium should then be replaced with a lower dose that inhibits
extracellular bacterial growth but not intracellular survival of the bacteria during
extended incubations. The data from extended incubations with gentamicin (Fig.
4-2) suggest that this maintenance dose should not exceed 2 µg/ml. To test
these empirically derived gentamicin concentrations, peritoneal or RAW264.7
macrophages were infected with YP043, a fully virulent strain of Y. pestis CO-92
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expressing the LuxPtolC bioluminescent bioreporter [140]. Twenty min later,
gentamicin was added at a final concentration of 8 µg/ml. Cells were incubated
for 1 h, washed with 1X PBS, and the medium was replaced with medium
containing 2 µg/ml gentamicin. Intracellular bacterial survival was monitored by
bacterial bioluminescence every 2 h for 20 h using an IVIS optical imager (Fig. 46). In peritoneal macrophages, bioluminescence slightly decreased over the first
~8 h of infection, indicating an initial inhibition of bacterial survival by the
macrophages, but then at ~12 h, bacterial bioluminescence began to increase,
reaching a steady state level at 16 h that was maintained for the remainder of the
infection (Fig. 4-6A). Based on our live imaging experiments, this steady state
level at later time points likely represents a balance between intracellular
replication and gentamicin killing of extracellular bacteria from lysed
macrophages (Fig. 4-1). In RAW264.7 macrophages we did not observe an initial
decrease in bacterial bioluminescence, supporting that this cell type is more
permissive to intracellular bacterial infection (Fig. 4-6B). Instead, we observed a
~2-fold increase in bioluminescence over the first 4 h, which plateaued at this
level for the first 10 h of the infection. Then, similar to the peritoneal
macrophages, at ~12 h post-infection, bacterial bioluminescence began to
increase, indicating further intracellular bacterial proliferation.

Discussion
The antibiotic protection assay has been a key technique for the study of
bacterial intracellular pathogenesis. The assay was originally developed on the
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premise that certain classes of antibiotics are excluded from eukaryotic cells,
resulting in antibiotic-mediated killing of extracellular bacteria but not intracellular
bacteria. While researchers have more recently recognized that antibiotics
originally thought to be excluded can inhibit the growth of several bacterial
pathogens, only a few systematic studies have been performed to characterize
the impact of antibiotic treatment on specific pathogens [116, 117]. We took
particular notice to this in the Yersinia field, where large variations in antibiotic
concentrations and exposure times have been reported in the literature [78, 122,
134-138, 143]. We were concerned that such variations in the antibiotic
protection assay between laboratories had the potential to decrease
reproducibility of experiments and potentially produce artificial phenotypes due to
unanticipated influence by the antibiotic. As such, our goals here were to
specifically demonstrate that variations in the gentamicin protection assay could
alter Y. pestis intracellular growth and suggest that researchers carefully
consider antibiotic concentrations and exposure times when designing future
intracellular experiments with Y. pestis (or any bacteria).
Through the use of live-cell microscopy we were able to observe Y. pestis
interactions with macrophages in the absence of gentamicin. These observations
suggest that washing of infected cells removes the majority of bacteria not
phagocytosed by the macrophages, resulting in the absence of extracellular
growth during the first several hours of the experiment. However, infected
macrophages eventually lyse and release viable Y. pestis into the medium.
These bacteria then replicate extracellularly. Importantly, our experience with live
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cell microscopy suggests that macrophage lysis is not synchronized and the
timing of when macrophages lyse and initiation of extracellular growth can vary
from experiment to experiment. Therefore, more conventional assays to study
intracellular proliferation without microscopy will require addition of an antibiotic
in the medium to ensure that extracellular growth is not mistaken for intracellular
growth. However, the data reported here also suggest that researchers should
carefully optimize the gentamicin protection assay to minimize potential artificial
influence on the system. Using an empirical approach, we defined the maximum
concentrations of gentamicin that should be used in a two-step gentamicin
protection assay as 8 µg/ml and 2 µg/ml (Fig. 4-6). These concentrations
represent the maximum concentrations of gentamicin that inhibit Y. pestis growth
without demonstrating a significant impact on intracellular numbers (as compared
to live microscopy in the absence of antibiotic). However, important
considerations in optimizing intracellular assays are not only antibiotic
concentration and exposure time, but also how Y. pestis is handled prior to
interactions with host cells and the cell type being used. For example, while our
data indicates that one hour incubation with 8 µg/ml of gentamicin is the
minimum bactericidal concentration for Y. pestis, this was determined for early
logarithmically growing bacteria. We have observed that for stationary phase
cultures, 16 µg/ml of gentamicin is required to eliminate all extracellular bacteria
in one hour [130, 140]. Furthermore, our data comparing peritoneal and
RAW264.7 macrophages support that researchers should not assume that
empirically determined gentamicin concentrations that do not influence
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intracellular growth in one cell type will not alter growth in another. Wendte et al.
also recognized differences in intracellular Y. pestis sensitivity to gentamicin
between THP-1 and RAW264.7 macrophages [144]. Therefore, different
macrophages may require concentrations different from those used here. In
summary, we hope these studies help researchers reconsider the potential
impact of gentamicin on Y. pestis intracellular growth when designing future
experiments using the antibiotic protection assay.
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Table 4-1. Yersinia pestis strains used in this study.
Strain

Relevant

Bioreporter

Source

pGEN222::mCherry

This study

pGEN222::EGFP

[130]

LuxPtolC

[140]

LuxPtolC

[140]

Characteristics
YPA165

CO92pgm(-)
pCD1(+)

YPA081

CO92 pgm(+)
pCD1(-)

YPA050

CO92 pgm(+)
pCD1(-)

YP043

CO92 pgm(+)
pCD1(+)
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Figure 4-1. Live imaging of Y. pestis in the absence of gentamicin. (A and B)
Primary peritoneal macrophages were infected with Y. pestis YPA165 expressing
mCherry (red symbols; pCD(+)) or Y. pestis YPA081expressing EGFP (blue
symbols; pCD(-)) at a MOI=3. One h after infection, cells were washed to remove
extracellular bacteria and macrophages were imaged by live confocal
microscopy. Bacterial numbers as a function of total fluorescent (RLU) area per
field were determined every 1 h for 24 h. Each point represents the mean ±S.D.
calculated from four imaged fields at each time point (an average of 16 infected
cells per field). (C) Representative images of Y. pestis YPA165 infected
macrophages at indicated time points during the infection. Individual
macrophages tracked through the entire course of the experiment are outlined in
different colors. Lysed macrophages at 24 h are highlighted by dotted lines.
Presence of extracellular bacteria at 18.2 h are highlighted by arrows.
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Figure 4-2. Extended incubations with gentamicin inhibit Y. pestis
intracellular survival. Primary peritoneal macrophages were infected with Y.
pestis YPA050 at an MOI of 10 (n=6). 20 min post-infection, macrophages were
washed and the medium was replaced with medium containing gentamicin at
indicated concentrations. Bacterial numbers as a function of bioluminescence
were determined every 3 h for 20 h using a plate reader and displayed as the
mean ±S.D. (in some cases the S.D. is smaller than the symbol size). Data is
shown from one representative experiment of three independent experiments.
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Figure 4-3. Cell type can influence intracellular sensitivity of Y. pestis to
gentamicin. Primary peritoneal macrophages (circles, dotted lines) or
RAW264.7 macrophages (squares, solid lines) were infected with Y. pestis
YPA050 at an MOI of 10 (n=6). 20 min post-infection, macrophages were
washed and the medium was replaced with medium containing gentamicin at
indicated concentrations. Bacterial numbers as a function of bioluminescence
were determined every 3-6 h for 20 h using a plate reader. Bioluminescent data
from each time point was normalized to fold change compared to the 2 h time
point by dividing each time point by the 2 h time point and is displayed as mean
fold change ±S.D. Data is shown from one representative experiment of three
independent experiments.
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Figure 4-4. Minimum inhibitory concentration of gentamicin for Y. pestis.
Logarithmically growing Y. pestis YPA050 was diluted to 1.5 x106 CFU per well in
a 96 well plate containing gentamicin at the indicated concentrations. (A) One h
after inoculation into gentamicin, bacteria were removed, serially diluted in 1x
PBS, and enumerated on agar to determine bacterial viability after exposure to
gentamicin (n=3). (B) Primary peritoneal macrophages were infected with Y.
pestis YPA050 at an MOI of 10 (n=3). 20 min post-infection, gentamicin was
added at indicated concentrations. One h later, the medium and washes were
collected, combined, and serially diluted to enumerate viable bacteria by plating
dilutions on BHI agar. Each point represents one sample and the bars represent
the mean CFU. The dotted lines indicate the limit of detection. Data is shown
from one representative experiment of three independent experiments. (A and B)
ANOVA with Dunnett’s post hoc analysis was used when comparing samples to
0 µg/ml gentamicin. (B) ANOVA with Tukey’s post hoc analysis was used when
comparing between the 4 – 32 µg/ml samples. **= p≤0.01; ****= p≤0.0001; ns=
not significant.
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Figure 4-5. Short incubations with gentamicin impact Y. pestis intracellular
survival in a dose dependent manner. Primary peritoneal macrophages were
infected with Y. pestis YPA050 at an MOI of 10 (n=3). 20 min post-infection, the
medium was replaced with medium containing gentamicin at indicated
concentrations. One h later, gentamicin was removed, and (A) cells were washed
three times, lysed with 0.1% Triton, and intracellular bacterial were enumerated
by serial dilution and plating on BHI agar plates, or (B) fresh medium without
gentamicin was added and cells incubated for an additional 23 h. At 23 h postgentamicin treatment, the medium was removed, cells were washed three times,
lysed with 0.1% Triton, and intracellular bacterial were enumerated by serial
dilution and plating on BHI agar plates. Each point represents one sample and
the bars represent the mean CFU. Data is shown from one representative
experiment of three independent experiments. ANOVA with Dunnett’s post hoc
analysis compared to 0 µg/ml gentamicin: *= p≤0.05; **= p≤0.01; ***= p≤0.001;
****= p≤0.0001.
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Figure 4-6. Optimized gentamicin protection assay. Primary peritoneal
macrophages were infected with Y. pestis YP043 at an MOI of 10 (n=6). 20 min
post-infection, macrophages were washed and the medium was replaced with
medium containing 8 µg/ml gentamicin. One h later, culture medium was
removed, cell were washed with 1X PBS, and fresh medium containing 2 µg/ml
gentamicin was added. Bacterial numbers as a function of bioluminescence were
determined every 2 h for 20 h using an IVIS Spectrum optical imager.
Bioluminescent data from each time point was normalized to fold change
compared to the 2 h time point by dividing each time point by the 2 h time point
and is displayed as mean fold change ±S.D. (in some cases the S.D. is smaller
than the symbol size). Data is shown from one representative experiment of two
independent experiments.
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Figure 4-7. Minimum inhibitory concentration of gentamicin for KIM D19 Y.
pestis. Logarithmically growing KIM D19 Y. pestis pCD1(-) LuxPtolC was diluted to
1.5 x106 CFU per well in a 96 well plate containing gentamicin at the indicated
concentrations. (A) One h after inoculation into gentamicin, bacteria were
removed, serially diluted in 1x PBS, and enumerated on agar to determine
bacterial viability after exposure to gentamicin (n=3). Each point represents one
sample and the bars represent the mean CFU. The dotted lines indicate the limit
of detection. Data is shown from one representative experiment of three
independent experiments. ANOVA with Dunnett’s post hoc analysis compared to
0 µg/ml gentamicin: **= p≤0.01; ****= p≤0.0001; ns= not significant.
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CHAPTER FIVE
ROLE OF YAPE AND PLA IN INTRACELLULAR SURVIVAL OF Y. PESTIS
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Introduction:
Recent studies have shown that the uptake of Y. pestis by host cells such as
macrophages, and to a lesser degree, neutrophils, is important for survival and
replication [122] [132]. During initial infection, outer membrane proteins are
expressed that aid in the uptake of the bacteria into the phagocytes. Many of
these outer membrane proteins are adhesins that help mediate adherence to
eukaryotic cells.
One adhesin, Ail, has been shown to target neutrophils in vivo, although there
does not appear to be a specific cell type that it directly mediates binding [145].
Although the characteristics of Ail in relation to the T3SS have been extensively
studied, to date, there is little to no information on the role Ail may play in
intracellular survival. The adhesin, OmpA, has been shown to contribute to
intracellular survival [104]. Bartra and co-workers infected RAW264.7
macrophages using KIM5-3001 WT strain or an ∆ompA strain, and showed that
by 24 hours there was a statistical difference in bacterial survival (P<0.05) [104].
Two adhesins that have played an integral role in the virulence of Y. pestis are
YapE and Pla. YapE and Pla have both demonstrated that they mediate
adherence to macrophages [77]. Moreover, strains deficient in either of these
adhesins are attenuated in dissemination and colonization of lymph nodes and
organs [53, 76]. It has been observed that at the site of subcutaneous infection,
macrophages migrate away from the site and travel to a draining lymph node.
The absence of either adhesin may cause a reduction of bacteria taken up by the
macrophages. This reduction of bacteria may have downstream effects that can
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influence the bacterial colonization. Another possibility for the reduction in
dissemination and colonization is that these adhesins play a role in intracellular
survival.
To confirm the role these known adhesins may play in intracellular survival,
strains lacking these genes (∆ail, ∆ompA, ∆yapE, and ∆pla) were used to infect
macrophages and their survival was monitored by bioluminescence.
Results:
Absence of outer membrane adhesins can influence intracellular survival
To investigate intracellular survival of the above mentioned adhesins, I used a
bioluminescent reporter strain containing individual mutations in ail, ompA, yapE
or pla and compared survival against WT Y. pestis (Table 5-1) in RAW264.7
macrophages. Macrophages were infected with an MOI of 10 monitored over 22
h. YPA147 (∆ail) showed no change in intracellular survival compared to WT
over the course of the experiment (T=22h) (Fig 5-1). Conversely, there was a
significant reduction of viable bacteria seen in the YPA148 (∆ompA) strain
compared to WT by the 11h time point and continued for the duration of the
experiment (T=22 h) (P<0.0001) (Fig 5-2). YPA145 (∆pla) showed a reduction in
bacterial numbers starting at 12 h post-infection (P<0.01) and showed higher
statistical significance at 24 h (P<0.0001) (Fig. 5-3). YPA087 (∆yapE) showed
statistical differences at both 10 h (P<0.001) and 24 h (P<0.01) (Fig.5-4).
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Discussion:
Adhesins are important to the spread of disease due to their ability to adhere to
eukaryotic cells, avoid complement and other subversions of the immune system.
These systems are in place to help with the fitness of the bacteria and allow for
increased virulence. I have shown that Ail does not impact intracellular survival,
while an ompA mutant does have a survival defect intracellularly [104]. Although I
did observe a survival defect with the ompA mutant, it is not due to reduced
adherence or invasion. Bartra and co-workers examined the initial uptake, by
cultured macrophages, of an ompA mutant and an isogenic ompA+ strain and
found the uptake comparable [104]. It was only at the later time point they saw a
reduction in bacterial numbers. This is because OmpA does not have the same
function of promoting adherence and invasion in Y. pestis like other bacterial
pathogens; to this end, their data identified ompA as a pro-survival gene that
promotes intracellular survival in Y. pestis [104]. The two other adhesins that
have played an integral role in the virulence are YapE and Pla. The intracellular
attenuation of ∆yapE, although statistically significant, may not be biologically
significant. There was a more significant attenuation at the 10 h time point than
seen at 24 h. This may be in part because other adhesins are compensating for
loss of YapE.
For Pla, vanLier and co-workers showed that the single pla mutant was not able
to survive in RAW264.7 macrophages [143]. I too was able to show an
attenuated phenotype for a pla mutant intracellularly but not complete clearance.
To this end, I tried to recapitulate their findings only to show that the clearance
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they reported may be a byproduct of antibiotic killing by way of the gentamicin
protection assay. While other studies have shown that there is an attenuation in
intracellular survival, they showed complete clearance by 12 hours where we
saw less than a log difference when using 8 µg/ml of gentamicin (Fig. 5-3A). To
confirm that the concentration of gentamicin was impacting intracellular growth, I
used 128 µg/ml to kill for 1 hour and saw virtually the same reduction in bacterial
numbers (Fig. 5-3B). One possible reason for the difference in bacterial
clearance demonstrated by the van Lier group is that the strain of bacteria they
used contained the pgm locus where our study did not use a strain containing the
pgm locus. This is confounding because the rip (required for intracellular
proliferation) operon is located within the pgm locus that allows for survival and
replication intracellularly. It would be assumed that if the pgm locus is present the
bacteria would have an advantage to survive intracellularly where the removal
should result in the reduction of bacterial numbers. One reason I did not see the
reduction in bacterial numbers with the ∆pgm strain is that the rip operon is
important for Y. pestis replication in activated macrophages [146, 147]. When
performing the gentamicin protection assay, the macrophages were not
stimulated prior to infection. This is why the absence of the pgm locus did not
appear to effect intracellular survival in this case.
Adherence and invasion assays were performed with the yapE and pla mutants
and for both there was no difference in adherence compared to WT (Fig 5-5 and
Fig. 5-6 respectively). Although there was a statistical significance see in
invasion with the pla mutant because the percentage is so minute, I do not

85

believe that this finding is biologically significant. This shows that the adherence
and uptake by the macrophages is not impacted by the mutations of yapE and
pla. Further studies are needed to understand the mechanisms that these
adhesins use that may mediate intracellular survival of Y. pestis. The survival
defect observed with a pla mutant may also be predicated on other adhesins that
pla may either activate or degrade.
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Table 5-1. Yersinia pestis strains used in this study.
Strain

Mutation

Relevant

Bioreporter

Source

LuxPtolC

This study

LuxPtolC

This study

LuxPtolC

This study

LuxPtolC

This study

LuxPtolC

This study

LuxPtolC

[140]

Characteristics
YPA143

CO92pgm(-)
pCD1(+)

YPA145

∆pla

CO92 pgm(-)
pCD1(+)

YPA147

∆ail

CO92 pgm(-)
pCD1(+)

YPA148

∆ompA

CO92 pgm(-)
pCD1(+)

YPA087

∆yapE

CO92 pgm(+)
pCD1(-)

YPA050

CO92 pgm(+)
pCD1(-)
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.
Figure 5-1 ∆ail does not exhibit an intracellular survival defect. . RAW264.7
macrophages were infected with Y. pestis YPA147 (n=12) or YPA143 (n=12) at
an MOI of 10. Bacterial numbers were determined at 5, 11, 17 and, 22h using a
plate reader measuring bioluminescence. Each time point was normalized to fold
change compared to the 2 h time point by dividing each time point by the 2 h time
point and is displayed as mean fold change ±S.D. (ns = no significance) Data
shown is from one representative experiment of three independent experiments.
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Figure 5-2 ∆ompA is attenuated intracellularly. RAW264.7 macrophages were
infected with Y. pestis YPA148 (n=12) or YPA143 (n=12) at an MOI of 10.
Bacterial numbers were determined at 5, 11, 17 and, 22h using a plate reader
measuring bioluminescence. Each time point was normalized to fold change
compared to the 2 h time point by dividing each time point by the 2 h time point
and is displayed as mean fold change ±S.D. (**** = P<0.0001)
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Figure 5-3 ∆pla is attenuated intracellularly. (A and B) RAW264.7
macrophages were infected with Y. pestis YPA148 (n=12) or YPA143 (n=12) at
an MOI of 10. Gentamicin protection assay was used to determine intracellular
bacteria viability using killing concentrations of 8 µg/ml (A) and 128 µg/m (B).
Bacterial numbers for each experiment were determined at 2, 4, 8, 12 and 24h
using a plate reader measuring bioluminescence. Each time point is reflective of
the bioluminescence emitted as a reflection of bacterial numbers. Student t-test
was used (**** = P<0.0001).

90

10 hr survival
2.5

***

Fold-change

2.0
1.5
1.0
0.5

W


ya
pE

T

0.0

24 hr survival

Fold-change

20
15

**

10
5

W


ya
pE

T

0

Figure 5-4. ∆yapE exhibits an intracellular survival defect. . RAW264.7
macrophages were infected with Y. pestis YPA087 (n=18) or YPA050 (n=18) at
an MOI of 10. Bacterial numbers were determined at 10 and 24 h using a plate
reader measuring bioluminescence. Time points were normalized to fold change
compared to the 2 h time point by dividing each time point by the 2 h time point
and is displayed as mean fold change ±S.D. (*** = P<0.001, ** = P<0.01)
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Figure 5-5 ∆yapE does not influence invasion or adherence. RAW264.7
macrophages were infected with Y. pestis YPA087 (n=18) or YPA050 (n=18) at
an MOI of 10. Bacterial numbers for invasion was determined by taking
bioluminescent readings after the bacteria was added to the macrophages (T=5
min) and dividing by the 2 h time point after the gentamicin protection assay to
get a percentage of intracellular bacteria compared to initial bacterial numbers.
Adherence was determined by dividing bacteria added to the macrophages (T=5
min) and dividing by the 20 minute time point after the cells had been washed
twice with sterile 1X PBS. Invasion and adherence data was acquired using RLU
readout as a function of bacterial numbers.
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Figure 5-6 ∆pla does influence invasion but not adherence. RAW264.7
macrophages were infected with Y. pestis YPA138 (n=18) or YPA050 (n=18) at
an MOI of 10. Bacterial numbers for invasion was determined by taking
bioluminescent readings after the bacteria was added to the macrophages (T=5
min) and dividing by the 2 h time point after the gentamicin protection assay to
get a percentage of intracellular bacteria compared to initial bacterial numbers.
Adherence was determined by dividing bacteria added to the macrophages (T=5
min) and dividing by the 20 minute time point after the cells had been washed
twice with sterile 1X PBS. Invasion and adherence data was acquired using RLU
readout as a function of bacterial numbers. (*** = P<0.0001)
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CHAPTER SIX
DISCUSSION AND FUTURE DIRECTIONS
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Research Summary
The evaluation of the role adhesins play in the virulence of Y. pestis has been
widely studied in how they are able to resist complement, aggregate for wider
dissemination and their contribution to overall fitness of the bacteria. In the studies
that have been previously outline, I explore the regulation and intracellular survival
of the virulence factors yapE and Pla.
While investigating how yapE is regulated, we found that many of the transposon
insertion sites were found in sugar processing and metabolizing genes. There was
one insertion into a putative phage protein, where I was unable to induce the
expression of yapE. I believe that this is because the true regulator is either 1) an
essential gene or 2) the regulator is a sRNA that has not been annotated within the
bacterial sequence. After doing and extensive search of the YapE sequence
against the published sRNAs, I was unable to find a match between the annotated
sRNA with the promoter region of yapE. I believe that further investigation of sRNAs
should be continued because data has shown that sRNAs have regulatory control
over stress response such as iron depletion and sugar stress. This could be another
reason why I was able to get a positive response when sugar transport and
metabolism genes had transposon insertion. sRNAs are also implicated in the
regulation of outer membrane proteins including porins and adhesins [94]. To this
end, I recommend the following future aims to evaluate sRNAs for regulation of
yapE: To determine how yapE is being regulated I would focus on 3 sRNAs that
have been shown to regulate crp, hfq and Ysr170 By modulating the expression
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levels of target genes, sRNAs can enable rapid adaptation of cellular physiology in
response to environmental change. [148].
Outer membrane proteins processes by pla:
Pla has been shown to process and/or degrade outer membrane proteins and
analysis performed by 2-DIGE and mass spectrometry showed at least 76 proteins.
Because I only looked at the top ten proteins under the parameters of >2-fold
increase or decrease of expression, there is a strong chance that I missed out on
some that may have worked in concert with other proteins that may have influence
other factors of cleavage or degradation. Future directions is to further investigate
the proteins that were not evaluated and explore the role those proteins may play in
the virulence of Y.pestis.
Intracellular survival of mutations ∆ail, ∆ompA, ∆yapE and ∆pla
When evaluating intracellular survival by the yapE mutant, there was only a slight
attenuation observed that was statistically significant but not believed to be
biologically relevant. This may be in part to the redundancy of other
autotransporters and adhesins that may compensate for the lack of one of their
expression. As stated previously, the attenuation observed in the ∆ompA strain may
be more attributed to its inability to resist complement and targeted by PMNs early
in infection and thereby decreasing the amount of bacteria that is being taken up by
the macrophages. As for the pla mutation, this may also be a two-fold reason for the
reduction of bacteria due to its primary role of being a protease. The inability to
activate plasminogen to allow for the dissemination of the bacteria allows for fewer
bacteria to migrate to draining lymph nodes. Moreover, as shown in previous
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studies, Pla also degrade Yops. Intracellularly, if Yops are identified early in the
macrophage they are able to illicit a response from the inflammasome that can
cause the cell to enter pyroptosis effectively killing the bacteria.
Future direction:
Is ∆pla attenuated intracellularly due to the inability to degrade Yops?
To evaluate if the degradation of Yops are a fundamental cause for the survival
defect observed in a pla mutant, I would infect macrophages with a T3SS/pla
double mutation and compare the viability against the single pla mutant. In addition
to an infection study to observe the intracellular survival defect, after infecting with a
∆pla strain of Y.pestis, test for ruptured plasma membrane, and/or DNA
fragmentation. Both signal that the cell is going under pyroptosis and a hallmark of
inflammasome activation.
Does double elimination of yapE and pla increase attenuation?
To investigate attenuation intracellularly when pla and yapE are mutated, I would
look at performing an infection using a strain that was ∆pla and ∆yapE to see if the
attenuation is more severe than they are individually. Previous studies have shown
when 2 or more outer membrane proteins (Ail and Pla) were mutated that there was
significant attenuation [149]. Ail being one of the outer membrane proteins that we
found in our 2-D/mass spec screen showed that there was a decreased in a pla
mutant. This may show that Pla’s involvement in intracellular survival may be in
tandem with other outer membrane proteins. When using a ∆pla and ∆yapE dual
mutant, I would look at the reduction of bacterial attachment and uptake with
macrophages. This may show that the processed form of YapE that is key to
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activation for adhesion but its full form may contribute to being noticed by the cell
that would increase its elimination by the cell. To follow up on the processing event
of YapE, I would also investigate mutating the site Pla recognizes to cleave YapE
and if that may play a role in intracellular survival.
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